The Missing Ingredient in HIV Care: Dignity
Pakistan’s HIV response can count how many people are tested, how many are diagnosed, how many begin antiretroviral treatment and how many remain connected to care. These numbers are essential for understanding the epidemic and assessing the health system’s response. What is much harder to count is what happens to a person during that care. Was their privacy protected? Were they spoken to respectfully? Were they able to ask questions without being judged? Did they understand and participate in decisions about their treatment? Did they leave the healthcare facility feeling that their dignity had been respected?
These questions are particularly important for transgender people living with HIV. A healthcare system may provide the correct medicine and still fail a patient in other fundamental ways. A consultation conducted without privacy, unnecessary disclosure of HIV status, disrespect for a person’s identity or judgemental questioning can all undermine the quality of care. Dignity is sometimes treated as an abstract human-rights principle, separate from the practical business of medicine. It is not. Privacy, confidentiality, informed consent, respectful communication and freedom from discrimination are all part of good healthcare.
This distinction matters because HIV treatment is about more than prescribing medicines. Antiretroviral therapy has transformed HIV from a once life-threatening diagnosis into a manageable chronic health condition for people who can access and continue effective treatment. Good HIV care therefore requires a relationship between patients and the health system that may continue for many years. Clinical competence is essential, but so is trust. A patient needs to be able to discuss symptoms, treatment concerns and personal circumstances honestly, knowing that sensitive information will be handled professionally and confidentially.
For transgender people, the quality of that relationship can be shaped by experiences that have little to do with HIV itself. A patient may arrive at a healthcare facility after years of social exclusion, family rejection, harassment or discrimination in other institutions. Their identity documents may not correspond with their gender expression or the name they use. They may have experienced disrespect in previous encounters with healthcare workers. None of this changes their entitlement to professional healthcare. Nor should a transgender person have to explain or defend their identity before a healthcare professional begins treating the medical condition that brought them there.
The World Health Organization has emphasised the importance of person-centred and stigma-free HIV services, including healthcare environments in which people can receive quality care without discrimination. This approach is important because dignity is not simply about making patients feel comfortable. It affects communication, trust and the relationship between healthcare providers and the people they serve. A patient who believes that a healthcare professional respects them is more likely to communicate openly about concerns. A health system that protects confidentiality also gives people greater confidence that seeking treatment will not create problems elsewhere in their lives.
Language is part of this discussion. Transgender people are still frequently described through the language of “risk”, particularly in discussions about HIV. Public-health programmes need terminology that identifies populations disproportionately affected by an epidemic, but people should never disappear behind epidemiological categories. A transgender person is not a risk factor. HIV vulnerability can be shaped by circumstances including discrimination, violence, economic exclusion, insecure housing, limited access to health information and barriers within healthcare itself. People are not risks; circumstances create risk, and systems can either increase vulnerability or reduce it.
Recognising dignity as part of healthcare quality also changes how HIV programmes should evaluate success. Treatment numbers, testing coverage, retention in care and viral suppression remain critical indicators. But numbers alone cannot reveal whether a patient’s confidentiality was breached, whether someone experienced discrimination during treatment or whether people feel able to raise concerns about the care they receive. If health programmes want to become genuinely person-centred, the experience of patients must become part of how quality is understood and assessed.
This does not require creating an entirely new health system for transgender people. It requires existing systems to uphold standards that should apply to everyone. Healthcare workers should understand confidentiality and informed consent. Registration procedures should avoid unnecessary humiliation. Medical questions should be clinically relevant and asked respectfully. Information about a person’s HIV status should only be accessible to those who legitimately require it for care. Facilities should also have safe and credible mechanisms through which patients can report discrimination, breaches of confidentiality or other mistreatment without fearing retaliation.
Training healthcare workers is important, but training alone is unlikely to transform institutional culture. Hospitals and HIV programmes also need accountability. Professional standards must be communicated clearly, supervisors need to respond when those standards are violated, and complaints should lead to appropriate action rather than disappear into administrative systems. Respectful treatment cannot depend on whether a patient happens to encounter a particularly sympathetic doctor or nurse. It should be an institutional expectation.
Community participation is equally important. Transgender people living with HIV should not only appear in programme documents as beneficiaries or target populations. Their experiences can help identify problems that may remain invisible in routine health statistics. Involving transgender communities in designing services, reviewing patient experiences, developing staff training and monitoring quality can help health institutions understand where apparently minor administrative practices create significant barriers. Nothing about us without us should be more than a slogan; participation should influence how services are actually delivered.
Pakistan’s HIV response therefore needs to look beyond the question of whether treatment is available and examine the quality and humanity of the care surrounding that treatment. A programme can meet numerical targets while individual patients continue to experience breaches of confidentiality, disrespect or exclusion. Conversely, a healthcare environment built around professional competence and respect can strengthen trust between communities and institutions. The objective should not be to replace clinical indicators with measures of dignity, but to recognise that both tell us something important about whether a health system is working.
For transgender people living with HIV, dignity is not a demand for special treatment. It is a demand for the same fundamental standards that every person should expect when seeking healthcare: privacy, confidentiality, informed consent, respectful communication, competent treatment and protection from discrimination. These principles do not compete with good medicine. They are part of good medicine.
The success of HIV care should therefore be measured not only by whether medicine reaches the patient, but also by how the patient is treated when it does. Dignity should never have been the missing ingredient in HIV care. It belongs at the centre of healthcare from the beginning.
Pakistan’s HIV response can count how many people are tested, how many are diagnosed, how many begin antiretroviral treatment and how many remain connected to care. These numbers are essential for understanding the epidemic and assessing the health system’s response. What is much harder to count is what happens to a person during that care. Was their privacy protected? Were they spoken to respectfully? Were they able to ask questions without being judged? Did they understand and participate in decisions about their treatment? Did they leave the healthcare facility feeling that their dignity had been respected?
These questions are particularly important for transgender people living with HIV. A healthcare system may provide the correct medicine and still fail a patient in other fundamental ways. A consultation conducted without privacy, unnecessary disclosure of HIV status, disrespect for a person’s identity or judgemental questioning can all undermine the quality of care. Dignity is sometimes treated as an abstract human-rights principle, separate from the practical business of medicine. It is not. Privacy, confidentiality, informed consent, respectful communication and freedom from discrimination are all part of good healthcare.
This distinction matters because HIV treatment is about more than prescribing medicines. Antiretroviral therapy has transformed HIV from a once life-threatening diagnosis into a manageable chronic health condition for people who can access and continue effective treatment. Good HIV care therefore requires a relationship between patients and the health system that may continue for many years. Clinical competence is essential, but so is trust. A patient needs to be able to discuss symptoms, treatment concerns and personal circumstances honestly, knowing that sensitive information will be handled professionally and confidentially.
For transgender people, the quality of that relationship can be shaped by experiences that have little to do with HIV itself. A patient may arrive at a healthcare facility after years of social exclusion, family rejection, harassment or discrimination in other institutions. Their identity documents may not correspond with their gender expression or the name they use. They may have experienced disrespect in previous encounters with healthcare workers. None of this changes their entitlement to professional healthcare. Nor should a transgender person have to explain or defend their identity before a healthcare professional begins treating the medical condition that brought them there.
The World Health Organization has emphasised the importance of person-centred and stigma-free HIV services, including healthcare environments in which people can receive quality care without discrimination. This approach is important because dignity is not simply about making patients feel comfortable. It affects communication, trust and the relationship between healthcare providers and the people they serve. A patient who believes that a healthcare professional respects them is more likely to communicate openly about concerns. A health system that protects confidentiality also gives people greater confidence that seeking treatment will not create problems elsewhere in their lives.
Language is part of this discussion. Transgender people are still frequently described through the language of “risk”, particularly in discussions about HIV. Public-health programmes need terminology that identifies populations disproportionately affected by an epidemic, but people should never disappear behind epidemiological categories. A transgender person is not a risk factor. HIV vulnerability can be shaped by circumstances including discrimination, violence, economic exclusion, insecure housing, limited access to health information and barriers within healthcare itself. People are not risks; circumstances create risk, and systems can either increase vulnerability or reduce it.
Recognising dignity as part of healthcare quality also changes how HIV programmes should evaluate success. Treatment numbers, testing coverage, retention in care and viral suppression remain critical indicators. But numbers alone cannot reveal whether a patient’s confidentiality was breached, whether someone experienced discrimination during treatment or whether people feel able to raise concerns about the care they receive. If health programmes want to become genuinely person-centred, the experience of patients must become part of how quality is understood and assessed.
This does not require creating an entirely new health system for transgender people. It requires existing systems to uphold standards that should apply to everyone. Healthcare workers should understand confidentiality and informed consent. Registration procedures should avoid unnecessary humiliation. Medical questions should be clinically relevant and asked respectfully. Information about a person’s HIV status should only be accessible to those who legitimately require it for care. Facilities should also have safe and credible mechanisms through which patients can report discrimination, breaches of confidentiality or other mistreatment without fearing retaliation.
Training healthcare workers is important, but training alone is unlikely to transform institutional culture. Hospitals and HIV programmes also need accountability. Professional standards must be communicated clearly, supervisors need to respond when those standards are violated, and complaints should lead to appropriate action rather than disappear into administrative systems. Respectful treatment cannot depend on whether a patient happens to encounter a particularly sympathetic doctor or nurse. It should be an institutional expectation.
Community participation is equally important. Transgender people living with HIV should not only appear in programme documents as beneficiaries or target populations. Their experiences can help identify problems that may remain invisible in routine health statistics. Involving transgender communities in designing services, reviewing patient experiences, developing staff training and monitoring quality can help health institutions understand where apparently minor administrative practices create significant barriers. Nothing about us without us should be more than a slogan; participation should influence how services are actually delivered.
Pakistan’s HIV response therefore needs to look beyond the question of whether treatment is available and examine the quality and humanity of the care surrounding that treatment. A programme can meet numerical targets while individual patients continue to experience breaches of confidentiality, disrespect or exclusion. Conversely, a healthcare environment built around professional competence and respect can strengthen trust between communities and institutions. The objective should not be to replace clinical indicators with measures of dignity, but to recognise that both tell us something important about whether a health system is working.
For transgender people living with HIV, dignity is not a demand for special treatment. It is a demand for the same fundamental standards that every person should expect when seeking healthcare: privacy, confidentiality, informed consent, respectful communication, competent treatment and protection from discrimination. These principles do not compete with good medicine. They are part of good medicine.
The success of HIV care should therefore be measured not only by whether medicine reaches the patient, but also by how the patient is treated when it does. Dignity should never have been the missing ingredient in HIV care. It belongs at the centre of healthcare from the beginning.
